$3,866.89 travel Payment -- Pfizer Inc to Dr. Kevin Hill
Pfizer Inc. pays $3,866.89 for travel and lodging to Oncology physician Dr. Kevin Hill
This page provides a detailed analysis of a $3,866.89 travel payment from Pfizer Inc to Dr. Kevin Hill. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $3,866.89 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Pfizer Inc |
| Physician | Dr. Kevin Hill |
| NPI Number | 1418723490 |
| Physician Specialty | Oncology |
| Location | Augusta, GA |
| Date of Payment | 2026-01-14 |
| Related Drug/Device | Dupixent |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Pfizer Inc made a $3.9K travel payment to Kevin Hill, a Oncology specialist in Augusta, GA. The payment was associated with Dupixent. The payment of $3,866.89 to Dr. Kevin Hill by Pfizer Inc. for travel and lodging related to Dupixent is a significant amount for a single payment. The payment occurred on January 14, 2026, indicating a recent engagement between the pharmaceutical company and the physician. The physician, Dr. Kevin Hill, specializes in Oncology, suggesting the travel may be related to educational events or discussions concerning Dupixent's use in cancer treatment or supportive care.
Patient Guidance: What This Payment Means for You
If you are a patient, this payment indicates your doctor may have received support for travel and lodging expenses from a pharmaceutical company, potentially related to educational activities about medications like Dupixent. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
While travel and lodging payments are common in the pharmaceutical industry, the amount of $3,866.89 for a single instance may be higher than average for some specialties, but could be within norms for extensive educational events or conferences in Oncology.
Regulatory Context: Sunshine Act Requirements
Payments for travel and lodging are subject to reporting requirements under the Sunshine Act, intended to promote transparency in financial relationships between healthcare providers and the pharmaceutical industry.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- oncology
- pfizer
- dupixent
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $3.9K payment for?
This was a travel payment of $3.9K from Pfizer Inc to Kevin Hill, categorized as "Travel and Lodging". It was associated with Dupixent. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Kevin Hill accept pharmaceutical money?
Yes, Kevin Hill received this $3.9K payment from Pfizer Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Kevin Hill's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $3.9K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Oncology?
To compare this payment against Oncology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Oncology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Kevin Hill's relationship with Pfizer Inc?
The payment covers 'Travel and Lodging', specifying the nature of the expenses covered by Pfizer Inc. This $3.9K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Oncology?
Dr. Hill's specialty is Oncology, which is a key area for many pharmaceutical research and development efforts.
What should patients do after learning about this payment?
If you are a patient, this payment indicates your doctor may have received support for travel and lodging expenses from a pharmaceutical company, potentially related to educational activities about medications like Dupixent.
What else should I know about this travel payment?
The payment is associated with Dupixent, a drug that treats conditions like asthma, eczema, and inflammatory bowel disease, which may have oncological implications or be used in patients with cancer.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.